Company research / DNLI
Denali Therapeutics Inc. (DNLI)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Denali Therapeutics Inc. reported revenue of $0.
Key ratios (year ended 2025-12-31)
-50.6%
Return on year-end equity
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.